Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2024-12-30 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about an upcoming Board Meeting scheduled for 4th February 2025. The purpose of the meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ending 31st December 2024. The document references Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed entities. The document does not contain any financial data or results itself, but is an announcement of a future event where financial results will be considered. The document length is only 1110 characters, which is short and consistent with an announcement rather than a full report. Therefore, this is an announcement of a Board Meeting and not the financial results report itself. The appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about an upcoming board meeting and financial results approval.
2024-12-30 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. It specifies the period of closure related to the upcoming announcement of unaudited financial results for the quarter ending 31st December 2024. The document does not contain any financial data, detailed report, or presentation. It is an announcement related to regulatory compliance and insider trading restrictions rather than a financial report or earnings release. Given the short length (1143 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-19 English
As per letter attached
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. It mentions the period of closure related to the announcement of unaudited financial results but does not contain any financial data or detailed report. The document is brief (1143 characters) and serves as an announcement rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-19 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of 'Letter(s) of Confirmation' in lieu of lost physical share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share transfer and related disclosures. The content is about notifying the exchanges of share certificate replacements, which is a regulatory announcement related to shareholding and share certificates. The document is short (1478 characters) and does not contain financial data, management discussion, or report content. It is not an annual report, earnings release, or any financial report. It is also not a director dealing or major shareholding notification but a regulatory compliance announcement. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-12-02 English
As per attached Letter
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of 'Letter(s) of Confirmation' in lieu of lost physical share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details about shareholders and share certificates. The content is about share certificate replacement and registrar activity, not about financial results, management changes, or other report types. It is a regulatory announcement related to shareholding records but does not fit into categories like Major Shareholding Notification (MRQ) or Share Issue/Capital Change (SHA) since it deals with lost certificates and confirmation letters. Given the nature and length (1478 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-12-02 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter dated 13th November 2024 addressed to stock exchanges (BSE and NSE) regarding the publication of unaudited financial results for the second quarter and half year ended 30th September 2024. It mentions the Board of Directors approved these unaudited financial results at a meeting held on 12th November 2024. The document states that the results were published in newspapers and are also available on the company's website. The key indicators are: - Reference to unaudited financial results for a quarter and half year period (Q2 and H1 2024). - Approval by the Board of Directors. - Publication in newspapers as per SEBI regulations. - The document is a notification/announcement of the publication of these financial results, not the full financial report itself. The document length is 15,000 characters, which is substantial, but the content is primarily an announcement of the publication of the unaudited financial results, including a newspaper advertisement copy. It does not contain detailed financial statements or substantive financial data analysis itself. Therefore, according to the "Menu vs Meal" rule, this document is an announcement of the report publication rather than the report itself. Hence, the appropriate classification is Report Publication Announcement (RPA).
2024-11-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.